Status:
COMPLETED
Changes in Microvascular Perfusion During Blood Purification With Cytosorb® in Septic Shock
Lead Sponsor:
Università Politecnica delle Marche
Conditions:
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Sepsis is defined as a life-threatening event due to a dysregulated immune response to an host. Blood purification techniques may be considered as a therapeutic weapon to front sepsis and septic shock...
Detailed Description
Introduction Sepsis is defined as a life-threatening event due to a dysregulated immune response to an infection. Blood purification techniques may be considered as a therapeutic weapon to front sepsi...
Eligibility Criteria
Inclusion
- age\>18
- septic patients with acute kidney failure that need to undergo CHHV treatment.
Exclusion
- hypersensitivity or allergy to the components of the cartridge
- pregnancy
- maxillary-facial trauma that prohibits mouth access and sublingual microcirculation evaluation.
Key Trial Info
Start Date :
December 9 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2017
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03456180
Start Date
December 9 2016
End Date
December 15 2017
Last Update
March 8 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.